Arcana Bio has received a 1 million ISK sustainability grant from Landsbanki, Iceland to support the company's ongoing development of its new rapid COVID-19 saliva test.
The grant, awarded for ArcanaBio's innovative and sustainable approach to disease detection supports the companies ongoing challenge to create a new more sensitive, faster and a more economically feasible biosurveillance platform that can be used to test saliva samples at-scale.